Calcelar 25 Dosage/Direction for Use

Oral.
The starting dosage for adults is 25 mg of Cinacalcet once daily, to be orally administered.
With careful management of the patient's serum parathyroid hormone (PTH) and calcium levels, the dose may then be adjusted within a range of 25-75 mg once daily. If no improvement is found in PTH, the dose may be increased up to 100 mg once daily. If dose increase is required, the dose should be increased by 25 mg at a time, at intervals of at least 3 weeks.
Precautions related to Dosage and Administration: Cinacalcet has an effect of decreasing calcium in blood. Therefore, it should be confirmed that the patient's serum calcium levels are not low [9.0 mg/dL (2.2 mmol/L) or more] prior to administration.
The serum calcium level should be determined once a week at the start of administration and during the dose adjustment period, and at least once every two weeks during the maintenance period. If serum calcium level decreases to 8.4 mg/dL (2.1 mmol/L) or less, the following measures should be taken. (See Table 1.)

Click on icon to see table/diagram/image

The serum level should be determined before administration of CALCELAR 25 mg Film Coated Tablet so that the effect and safety of the drug may be properly evaluated. Furthermore, it is recommended that corrected serum calcium values should be used as a guide in patients with hypoalbuminemia.
The serum PTH should be periodically determined so that it may be maintained at the target level for management. It is recommended that the serum PTH level should be determined twice a month at the start of administration and during the dose adjustment period (about 3 months after the start of administration), and at least once a month after the serum PTH level is confirmed to be almost stable. The serum PTH level should be determined before administration of CALCELAR 25 mg Film Coated Tablet so that the safety of the drug may be properly evaluated.